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Cholesterol-Rich Membrane Microdomains Mediate Cell Cycle Arrest Induced by
Actinobacillus Actinomycetemcomitans Cytolethal-Distending Toxin
Abstract
We have previously shown that Actinobacillus actinomycetemcomitans cytolethal-distending toxin (Cdt)
is a potent immunosuppressive agent that induces G2/M arrest in human lymphocytes. In this study, we
explored the possibility that Cdt-mediated immunotoxicity involves lipid membrane microdomains. We
first determined that following treatment of Jurkat cells with Cdt holotoxin all three Cdt subunits localize
to these microdomains. Laser confocal microscopy was employed to colocalize the subunits with
GM1-enriched membrane regions which are characteristic of membrane rafts. Western blot analysis of
isolated lipid rafts also demonstrated the presence of Cdt peptides. Cholesterol depletion, using methyl βcyclodextrin, protected cells from the ability of the Cdt holotoxin to induce G2 arrest. Moreover,
cholesterol depletion reduced the ability of the toxin to associate with Jurkat cells. Thus, lipid raft integrity
is vital to the action of Cdt on host cells. The implications of our observations with respect to Cdt mode of
action are discussed.
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Summary
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We have previously shown that Actinobacillus actinomycetemcomitans cytolethal-distending toxin
(Cdt) is a potent immunosuppressive agent that induces G2/M arrest in human lymphocytes. In
this study, we explored the possibility that Cdt-mediated immunotoxicity involves lipid membrane
microdomains. We first determined that following treatment of Jurkat cells with Cdt holotoxin all
three Cdt subunits localize to these microdomains. Laser confocal microscopy was employed to
colocalize the subunits with GM1-enriched membrane regions which are characteristic of
membrane rafts. Western blot analysis of isolated lipid rafts also demonstrated the presence of Cdt
peptides. Cholesterol depletion, using methyl β-cyclodextrin, protected cells from the ability of the
Cdt holotoxin to induce G2 arrest. Moreover, cholesterol depletion reduced the ability of the toxin
to associate with Jurkat cells. Thus, lipid raft integrity is vital to the action of Cdt on host cells.
The implications of our observations with respect to Cdt mode of action are discussed.

Introduction
Author Manuscript

The cytolethal-distending toxins (Cdts) are a family of heat-labile protein cytotoxins
produced by several different bacterial species including diarrhoeal disease-causing
enteropathogens such as Escherichia coli, Campylobacter jejuni, Shigella species,
Haemophilus ducreyi, Salmonella typi and Actinobacillus actinomycetemcomitans (Pickett
et al., 1994; Scott and Kaper, 1994; Okuda et al., 1995; 1997; Comayras et al., 1997; Mayer
et al., 1999; Pickett and Whitehouse, 1999; Shenker et al., 2000; Haghjoo and Galan, 2004).
We have previously shown that the Cdt derived from A. actinomycetemcomitans is a potent
immunotoxin capable of inducing G2 arrest and ultimately apoptosis in human lymphocytes
(Gelfanova et al., 1999; Shenker et al., 1999; 2001; Nalbant et al., 2003). There is now clear
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evidence that Cdt is encoded by three genes, designated cdtA, cdtB and cdtC, which encode
polypeptides with apparent molecular masses of approximately 24–35 kDa (Lara-Tejero and
Galan, 2001; Mao and DiRienzo, 2002; Deng and Hansen, 2003; Shenker et al., 2004).
Moreover, we have recently demonstrated that the Cdt holotoxin consists of each of the Cdt
subunits: CdtA, CdtB and CdtC. The Cdt holotoxin appears to function as an AB2 toxin
where CdtB is the active (A) unit and the complex of CdtA and CdtC comprise the binding
(B) unit (Elwell and Dreyfus, 2000; Lara-Tejero and Galan, 2001; Nesic et al., 2004).
Furthermore, it is generally agreed that the active subunit, CdtB, enters the cell while CdtA
and CdtC remain associated with the cell surface (Cortes-Bratti et al., 2000; McSweeney
and Dreyfus, 2004; Nesic et al., 2004).

Author Manuscript
Author Manuscript

It is well documented that plasma membranes consist of microscopically and biochemically
distinguishable lipid microdomains. Membrane bilayer organization into these
microdomains known, colloquially as membrane rafts and super-rafts, provides the requisite
temporal and spatial organization of protein and lipid components necessary for normal
cellular function (Simons and Ikonen, 1997; Brown and London, 1998; Zajchowski and
Robbins, 2002; Horejsi, 2004; Pike, 2004). A unique property of these membrane rafts is
their resistance to solubilization at low temperatures by mild detergents such as Triton
X-100, NP-40 and Brij; this insolubility is due, in part, to long saturated acyl chains of
gangliosides that impart a high degree of order and also by stabilization of intercalating
cholesterol molecules (Simons and Ikonen, 1997; Brown and London, 1998). In addition to
their unique lipid profile, membrane rafts also contain a number of extracellular and
cytoplasmic proteins involved in signal transduction. The organization of rafts restricts
access so that only limited proteins can reside in rafts; these include those attached to the
membrane by a lipid anchor, such as glycosylphosphatidylinoisitol (GPI)-anchored proteins,
acylated cytosolic proteins and certain transmembrane proteins (Simons and Ikonen, 1997;
Brown and London, 1998; Horejsi, 2004). Membrane rafts are involved in cellular processes
as diverse as fertilization, viral infection, maintenance of cell polarity, chemotaxis, apoptosis
and development (Simons and Ikonen, 1997; Brown and London, 1998; van der Goot and
Harder, 2001; Zajchowski and Robbins, 2002; Horejsi, 2003; 2004). Thus, it has been
proposed that rafts may play a pivotal role in the plasma membrane by serving as platforms
that co-ordinate the induction of signalling pathways. Indeed, lipid rafts isolated from
lymphocytes not only contain Src kinases but these membrane complexes also have been
implicated in regulating cell activation following engagement of the T-cell receptor (TCR)
as well as interleukin-2 receptor signalling (Xavier et al., 1998; Alonso and Millan, 2001;
Marmor and Julius, 2001).

Author Manuscript

In addition to a role in cell signalling, it has become increasingly evident that several
pathogens and microbial-derived toxins interact with their target cell via membrane rafts
(van der Goot and Harder, 2001). For instance, rafts may provide a mechanism by which
receptors are concentrated and thereby promote binding. One such example is cholera toxin
which is pentameric and binds to targets cells via the ganglioside GM1. It is likely that
cholera toxin simultaneously binds with high affinity to multiple receptors as result of
receptor concentration within the lipid microdomain (Montecucco et al., 1994; van der Goot
and Harder, 2001). Likewise, pore-forming toxins such as Aeromonas hydrophila, which
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binds to GPI-anchored proteins, utilize the concentrating properties of lipid rafts to facilitate
oligomerization, a requisite for channel formation (Abrami and van der Goot, 1999; van der
Goot and Harder, 2001). Membrane rafts may also facilitate signalling following the binding
of bacterial toxins to raft-associated receptors. In this regard, bacterial lipopolysaccharride
(LPS) interacts with rafts via CD14, a GPI-anchored receptor; LPS binding results in
mitogen-activated protein (MAP) kinase activation and eventually cytokine production.
Finally, membrane rafts may serve as entry sites for pathogens; in this regard several
pathogens enter host cells in a cholesterol-dependent manner (van der Goot and Harder,
2001; Lencer, 2001). Furthermore, the uptake of E. coli strains which express FimH have
been shown to involve cholesterol-rich microdomains. Similarly, Shigella invades cells via
interaction between the invasin, IpaB, and the raft-associated receptor, CD44. Viruses such
as SV40 also utilize rafts either for internalization or as a site for fusion with the plasma
membrane (Lafont et al., 2002).

Author Manuscript
Author Manuscript

It is clear that lipid microdomains play a pivotal role in regulating T-cell activation and
function. Moreover, there is growing evidence that several microbes specifically target raft
domains in order to infect host cells and/or hijack these signalling platforms to promote
pathogenic events. Therefore, we explored the possibility that Cdt-mediated immunotoxicity
is cholesterol dependent. We now report that Cdt colocalizes to membrane rafts. The
association of all three Cdt subunits with lipid rafts was evident from Western blot analysis
of isolated raft fractions and confocal microscopy of toxin-treated cells. Cholesterol
depletion of Jurkat cell membranes confers resistance to Cdt-induced G2 arrest indicating
that the integrity of cholesterol-rich microdomains is crucial to toxin activity. Finally,
cholesterol-depleted cells exhibited reduced ability to bind Cdt. These studies clearly
indicate that lipid rafts are indeed critical to the mechanism by which Cdt induces cell cycle
arrest in target cells.

Results

Author Manuscript

The Cdt holotoxin is composed of three truncated subunits: CdtA, CdtB and CdtC, and
furthermore, a complex of CdtA and CdtC is required for interaction of the toxin with target
cell membranes leading to toxin-induced G2 arrest. Moreover, following a 2 h exposure to
Cdt holotoxin, the individual subunits could be detected associated with Jurkat cell
membranes. We therefore wanted to determine whether any of the Cdt subunits associate
with membrane lipid microdomains. In order to conduct these experiments, we first needed
antibodies capable of recognizing the individual Cdt subunits when they are present in the
holotoxin complex and associated with cells. Monoclonal antibodies (mAbs) were generated
and characterized in terms of their peptide specificity by both Western blot analysis and
enzyme-linked immunosorbent assay (ELISA) as well as for their ability to recognize the
peptide in association with the holotoxin complex by surface plasmon resonance (data not
sown). Figure 1 shows flow cytometric analysis of Jurkat cells after they have been treated
with the Cdt holotoxin and then stained using three of these mAbs. The mAbs specifically
recognize either CdtA (Fig. 1A), CdtB (Fig. 1B) or CdtC (Fig. 1C) when the toxin is
associated with cells. These mAbs were used in this study to investigate the localization of
Cdt subunits to membrane lipid microdomains.
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To demonstrate that the Cdt subunits not only associate with the cell membrane, but localize
to lipid rafts, Jurkat cells were treated with the holotoxin and then dual stained to identify
individual Cdt peptides and GM1, a well-established marker for membrane rafts. Cells were
first exposed to cholera toxin B unit (CTB)-AlexaFluor 647 to identify GM1 and patches
representing microdomains were induced by treatment with anti-CTB antisera (Figs 2B, E
and H, 3B, E and H, 4B, E and H). Cells were then exposed to Cdt holotoxin for 2 h, washed
and stained with mAb to either CdtA, CdtB or CdtC (Figs 2D and G, 3D and G, 4D and G).
To control for non-specific staining with the anti-Cdt mAbs, isotype-matched control IgG
was used instead (Figs 2A, 3A and 4A). Analysis of merged images indicates that both CdtA
(Fig. 2F and I) and CdtC (Fig. 4F and I) colocalize with GM1 (CTB fluorescence); virtually
all CdtA (> 96%) and CdtC (> 88%) fluorescence is found associated with the GM1 patches.
In contrast, most, but not all, of CdtB fluorescence exhibited colocalization to GM1 (Fig. 3F
and I). Analysis of the fluorescence distribution indicates that only 70% of anti-CdtB
fluorescence is associated with GM1. While CdtB is known to enter cells, it should be noted
that these experiments only assessed Cdt subunits associated with the cell surface;
immunofluorescent staining was performed before permeabilization for DAPI staining.
Wheat germ agglutinin was also employed to verify that the toxin did not alter cell
permeability; no difference was noted in the immunofluorescent pattern for wheat germ
agglutinin in control cells versus Cdt holotoxin-treated cells (data not shown).

Author Manuscript

Further support for localization of Cdt peptides to cholesterol-rich microdomains was
obtained by isolating detergent-resistant membranes (DRMs) from both untreated (no toxin)
Jurkat cells and cells exposed to Cdt holotoxin. Following a 2 h incubation, Jurkat cells were
disrupted, homogenized in ice-cold Triton X-100 and ultra-centrifuged on a sucrose
gradient. Two distinct low-buoyant-density bands, designated DRM1 and DRM2, were
obtained (Fig. 5). The lipid and protein composition of these bands was analysed to verify
that they were indeed rafts. As shown in Fig. 5, both DRM1 and DRM2 were enriched in
GM1 (dot blot) and in total cholesterol. Scanning densitometric analysis of the blots
indicated that GM1 was approximately equal in DRM1 and DRM2 from both control and
toxin-treated cells. DRM1 isolated from toxin treated cells had a cholesterol/phosphate ratio
of 0.18; in contrast, the Triton X-100 soluble fraction had a ratio of 0.08. Similarly, DRM1
from untreated cells had a cholesterol/phosphate ratio of 0.14 and the ratio of the soluble
fraction was 0.08. Moreover, the raft-associated protein, Lck, was enriched in these fractions
as well. In contrast, the transferrin receptor (CD71), a non-raft-associated protein, was found
only in the soluble fraction.

Author Manuscript

The DRMs were also analysed to determine the relative distribution of toxin subunits (Fig.
6). Following treatment of Jurkat cells with Cdt holotoxin, the DRMs were isolated and
analysed by Western blot. All three subunits were found associated with DRM1; >95% of
CdtA and CdtC were associated with this fraction. In contrast, 80% of CdtB was present in
DRM1 and a significant amount of peptide was also observed in DRM2 (15.8%) as well as
in the soluble fraction (3.5%). It should be noted that the amount of CdtB present in the
soluble fraction was probably greater than 3.5% when total sample volume is taken into
account. CdtA and CdtC were minimally detected in DRM2, 1.6% and 5.4%, respectively;
neither of these subunits were found in the soluble fraction. Moreover, both CdtA and CdtC
were found to be required for toxin localization to membrane lipid rafts. CdtB was not
Cell Microbiol. Author manuscript; available in PMC 2016 January 29.
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detected in DRMs when cells were exposed to this subunit alone. In contrast, both CdtA and
CdtC were able to localize to DRM1 (> 98%) when Jurkat cells were treated with only these
two subunits. These results were not surprising as the CdtA and CdtC subunits have been
shown to be required for association of the holotoxin with cells.
In these studies we observed that the relative buoyancy of the DRM fractions differed upon
toxin treatment; DRMs from toxin treated cells routinely floated at 13% (DRM1) and 22%
(DRM2) sucrose while DRMs from untreated cells floated at 15% (DRM1) and 20%
(DRM2) sucrose. The change in the banding pattern of the DRMs prompted us to further
assess the lipid composition of membrane rafts from control and toxin-treated cells. As
shown in Table 1, there was no significant difference between the major classes of
phospholipids in control DRMs versus that of DRMs isolated from Cdt-treated cells. Also,
the phospholipid content of DRM1 and DRM2 were similar.

Author Manuscript
Author Manuscript

To determine whether Cdt action is dependent on membrane microdomains, we assessed
whether the integrity of these cholesterol enriched rafts was critical to Cdt-induced cell cycle
arrest. Jurkat cell membranes were depleted of cholesterol with 0–10 mM methyl βcyclodextrin (MβCD). After 30 min exposure, cells were washed, incubated for 18 h in the
presence of Cdt holotoxin (40 pg ml−1) and analysed for cell cycle distribution. Jurkat cells
exposed to only Cdt holotoxin exhibited 60% G2 cells (Fig. 7A); this compares with 15%
G2 cells in untreated controls (data not shown). Pre-treatment of Jurkat cells with 2.5–10
mM MβCD resulted in a dose-dependent reduction in Cdt holotoxin-induced G2
accumulation: 46.9% G2/M (2.5 mM; Fig. 7B), 32.3% G2/M (5.0 mM; Fig. 7C) and 27.1%
G2/M (10 mM; Fig. 7D). As reported by others, no cytotoxic effects of MβCD were noted at
these concentrations (Nguyen and Taub, 2002; Pizzo et al., 2002; Rajendran et al., 2003).
To control for MβCD effects unrelated to cholesterol depletion, Jurkat cells were also pretreated with cholesterol-saturated MβCD. Cells were treated as described above with
medium, 10 mM MβCD or 10 mM cholesterol-saturated MβCD, washed and then incubated
for 18 h in the presence of Cdt holotoxin. Jurkat cells exposed to medium only exhibited
15.2% G2/M cells (Fig. 8A) while cells exposed to toxin alone exhibited more than
threefold increase in the percentage of G2/M cells (49.3%; Fig. 8B). As shown in Fig. 8C,
cells first treated with 10 mM MβCD and then exposed to Cdt holotoxin exhibited only a
slight increase in G2/M cells (25%); this compares with 49% G2 cells when Jurkat cells
were pre-treated with cholesterol-saturated MβCD (Fig. 8D).

Author Manuscript

In another series of experiments, we observed that cholesterol reconstitution of MβCDtreated cells restores susceptibility to Cdt holotoxin. As shown in Fig. 9, pretreatment of
Jurkat cells with MβCD reduced cell susceptibility to Cdt-induced G2/M arrest. Control
cells contained 13.4% G2/M cells (Fig. 9A); the percentage of cells in the G2/M phase
increased in Cdt holotoxin-treated cells (62.9%; Fig. 9B) and cells pre-exposed to MβCD
and then treated with Cdt holotoxin exhibited 30.2% G2/M (Fig. 9D). Cholesterol repletion
of MβCD-treated cells with cholesterol-saturated MβCD restored susceptibility of Jurkat
cells to Cdt holotoxin; these cells contained 57.3% G2/M (Fig. 9F). It should also be noted
that Jurkat cells were not adversely affected by these agents; cell cycle profiles of cells
treated with either MβCD (Fig. 9C) or MβCD plus cholesterol-saturated MβCD (Fig. 9E) in

Cell Microbiol. Author manuscript; available in PMC 2016 January 29.

Boesze-Battaglia et al.

Page 6

Author Manuscript

the absence of toxin were similar to control cells (Fig. 9A). Thus, it appears that intact
membrane rafts are critical to the action of Cdt in lymphocytes.
In a final series of experiments, we assessed whether cholesterol depletion also altered the
ability of the toxin to associate with cells. Jurkat cells were pre-treated with 10 mM MβCD
for 30 min, exposed to Cdt holotoxin for 1 h and then the cells were analysed by flow
cytometry for the presence of toxin subunits on the surface following staining with anti-Cdt
mAb. As shown in Fig. 10, all three Cdt subunits could be detected on cells pre-incubated in
medium alone; mean channel fluorescence (MCF) was 34.9, 20.4 and 17.8 for anti-CdtA
(Fig. 10C), anti-CdtB (Fig. 10E) and anti-CdtC (Fig. 10G) respectively. Pretreatment of cells
with MβCD reduced toxin binding; the MCF was reduced for all three subunits: anti-CdtA
(9.0; Fig. 10D), anti-CdtB (13.0; Fig. 10F) and anti-CdtC (10.2; Fig. 10G).

Author Manuscript

Discussion

Author Manuscript
Author Manuscript

In this study, we provide evidence that Cdt preferentially associates with cholesterol-rich
membrane rafts. The association of Cdt subunits with lipid rafts was corroborated utilizing
two independent approaches. It is well established that lipid rafts are enriched in
glycosphingolipids, including the ganglioside GM1. GM1 can be detected within lipid
microdomains with CTB, the membrane-binding cholera toxin subunit. Once bound to
GM1, CTB is readily observed microscopically following patch formation induced by
exposing cells to anti-CTB. Utilizing this approach, we were able to demonstrate
colocalization of all three Cdt subunits with CTB bound to GM1. It is noteworthy that
essentially all of the CdtA subunit and most of the CdtC subunit co-patched with GM1. In
contrast, approximately 30% of CdtB was not associated with GM1. In addition to
microscopic colocalization, we also employed a biochemical approach to ascertain that Cdt
peptides associate with membrane rafts. Following treatment of Jurkat cells with Cdt
holotoxin, detergent-resistant cholesterol rich microdomains were isolated and assessed by
Western blot for the presence of toxin subunits. All three subunits were found within the
isolated rafts. Both CdtA and CdtC were restricted to the raft, whereas a portion of CdtB
was also observed to be in the soluble fraction. The Western blot is consistent with the
notion that CdtB enters the cell and that the other two subunits most likely remain
membrane associated. These findings are consistent with observations made by several
laboratories suggesting that CdtB, the active Cdt subunit, must enter the cell to induce cell
cycle arrest (Shenker et al., 1999; 2004; Cortes-Bratti et al., 2000; Lara-Tejero and Galan,
2000; McSweeney and Dreyfus, 2004; Guerra et al., 2005). Moreover, our studies clearly
demonstrate that CdtA and CdtC are required for localization to these membrane
micodomains; these results are consistent with the notion that CdtA and CdtC represent the
binding components of the holotoxin.
The microscopic and biochemical analyses provide strong support that the Cdt subunits
associate with lipid rafts. However, these data do not provide information as to whether the
microdomains actually participate in the sequence of toxin-induced events leading to cell
cycle arrest. A frequently employed approach to address this possibility consists of
disrupting rafts by extracting cholesterol with sequestering agents, such as MβCD. This drug
is efficient in extracting membrane cholesterol resulting in dispersal of the rafts into the
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plasma membrane; as a consequence the rafts are not only disrupted but also lose their
detergent-resistant properties. Thus, Jurkat cells were pre-treated with 2.5–10 mM MβCD
for 30 min, exposed to Cdt and then the cells were monitored for cell cycle progression.
Cells treated with MβCD were clearly resistant to Cdt-induced G2 arrest. These effects were
dependent on the dose of MβCD employed. MβCD has been shown to have a number of
other effects on cells besides depletion of cholesterol; these include plasma membrane
depolarization and inhibition of calcium mobilization among others (Pizzo and Viola, 2003).
To control for these effects, we also employed cholesterol-saturated MβCD which is not able
to extract cholesterol but retains the capacity to induce these other effects. Indeed,
cholesterol-saturated MβCD failed to inhibit Cdt-induced G2 arrest. In other experiments,
cholesterol reconstitution of MβCD depleted cells restored susceptibility to Cdt indicating
that MβCD was not toxic under these conditions. Collectively, these results clearly
demonstrate that the integrity of membrane lipid rafts is crucial to the action of Cdt.

Author Manuscript

An unanticipated effect of Cdt treatment was that the relative buoyancy of the DRMs from
toxin-treated cells changed suggesting that the lipid composition of membrane rafts had
been altered. Therefore, we analysed the lipid content of both DRM 1 and DRM2. Cdt
treatment did not induce any significant change in content of the major classes of
phospholipid in either DRM1 or DRM2. It is possible that the change in DRM buoyance is
the result of altered protein content; this possibility is the focus of ongoing studies.

Author Manuscript
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We have previously shown that the CdtA and CdtC subunits are responsible for the ability of
the Cdt holotoxin to interact with the cell surface. Furthermore, analysis of the crystal
structure of the holotoxin suggests that CdtA and CdtC together contribute towards the
formation of two notable surface elements; these include an aromatic cluster and a deep
groove both of which may be critical to the interaction of Cdt with the cell surface (Nesic et
al., 2004). Indeed, mutagenesis studies suggest that these structures are vital for toxin
activity. To date, no definitive receptor has been identified for Cdt although recent evidence
suggests that carbohydrate residues might be important (McSweeney and Dreyfus, 2005).
However, our studies do indicate that these membrane microdomains must be intact not only
for Cdt to intoxicate cells, but also to associate with cells as well. In conclusion, we
demonstrate that the Cdt holotoxin interacts with lipid rafts and that the integrity of these
microdomains is vital to both the binding and action of the toxin. This association between
Cdt subunits and lipid rafts significantly advances our understanding of how the holotoxin
interacts with host cells and raises several possibilities. Lipid microdomains have been
shown to serve as a site of attachment for pathogens and provide a means to concentrate
receptors for toxins and thereby increase binding affinity. These microdomains also play a
key role in triggering internalization and may provide a means of entry for the CdtB subunit
leading to retrograde transport through the trans-golgi network. Finally, rafts may also serve
as signalling platforms; this raises the possibility that a component of the mechanism of Cdt
action may indeed involve signal transduction. Studies are currently in progress to further
define the role of lipid rafts in action of this toxin.
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Experimental procedures
Preparation of Cdt holotoxin and Cdt peptides
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Recombinant Cdt holotoxin was used for most of the experiments described in this study.
Construction and characterization of the plasmid pUCAacdtABChis which expresses the Cdt
holotoxin containing a His tag on the CdtC peptide has previously been reported (Shenker et
al., 2004). The plasmid was constructed so that the cdt genes were under control of the lac
promoter; all ligation mixtures were transformed into E. coli DH5α. Cultures of transformed
E. coli were grown in 1 l of LB broth and induced with 0.1 mM IPTG for 2 h; bacterial cells
were harvested, washed and resuspended in 50 mM Tris (pH 8.0). The cells were frozen
overnight, thawed and sonicated. The His-tagged holotoxin was isolated by nickel affinity
chromatograpy as previously described (Shenker et al., 2000). Briefly, the sonicated
bacterial extracts were applied to a histidine-binding column (HiTrap Chelating HP;
Amersham Biosciences, Uppsala, Sweden). The column was washed and His-tagged
proteins were eluted with 500 mM imidazole; previous studies have demonstrated that the
isolated holotoxin, designated CdtABC, consists of a heterotrimeric complex of CdtA, CdtB
and CdtC (Shenker et al., 2004).
Individual Cdt peptides were expressed using an in vitro expression system; construction of
the plasmids pGEMCdtA, pGEMCdtB and pGEMCdtC was previously described (Shenker
et al., 2005). We employed the Rapid Translation System to express recombinant peptides
(RTS 500 ProteoMaster; Roche Applied Science); reactions were run according to the
manufacturer’s specification (Roche Applied Science) using 10–15 μg of template DNA.
After 20 h at 30°C, the reaction mix was removed and the expressed Cdt peptides were
purified by nickel affinity chromatography as previously described.

Author Manuscript

Cell culture and analysis of cell cycle

Author Manuscript

The T cell leukaemia cell line Jurkat (E6-1; American Type Tissue Culture Collection,
Manassas, VA) was maintained as previously described (Shenker et al., 2004). Briefly, cells
were maintained in RPMI 1640 supplemented with 10% FCS, 2 mM glutamine, 10 mM
Hepes, 100 U ml−1 penicillin and 100 μg ml−1 streptomycin. Cells were harvested in midlog growth phase and plated at 5 × 105 cells ml−1 in 24-well tissue culture plates or as
described below. The cells were exposed to medium, 2.5–10 mM MβCD (Sigma Chemical,
St Louis, MO) or 10 mM cholesterol-saturated MβCD; 0.5 mM cholesterol-saturated MβCD
was employed for repletion experiments. Cholesterol-saturated MβCD was prepared as
described by Christian et al. (1997). Following a 30 min incubation, cells were treated with
Cdt holotoxin or medium (control) and incubated for 18 h. To measure Cdt-induced cell
cycle arrest, Jurkat cells were washed and fixed for 60 min with cold 80% ethanol. After
washing, the cells were stained with 10 μg ml−1 propidium iodide containing 1 mg ml−1
RNase (Sigma Chemical) for 30 min. Samples were analysed on a Becton–Dickinson
FacstarPLUS flow cytometer (BD Biosciences, San Jose, CA). Propidium iodide fluorescence
was excited by an argon laser operating at 488 nm and fluorescence measured with a 630/22
nm bandpass filter using linear amplification. A minimum of 15 000 events were collected
on each sample; cell cycle analysis was performed using Modfit (Verity Software House,
Topsham, ME).
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Triton X-100-resistant membrane rafts were prepared from the T-cell leukaemia cell line
Jurkat (E6-1); the cells (2.0 × 106 cells ml−1) were incubated in T-75 flasks in the presence
of medium or Cdt holotoxin for 2 h. Following the incubation period, cells were washed in
MOPS buffer and detergent-resistant fractions were isolated as previously described
(Boesze-Battaglia et al., 2002). Briefly, the cell pellet (4–5 × 108 cells) was resuspended in
1.0 ml of MOPS buffer; Triton X-100 (2% w/v) was added to a final concentration of 1%
Triton X-100. To distinguish between Triton X-100-resistant membranes and simply a
partial detergent-dependent non-raft-specific solubilization, control cells were homogenized
in 1% OG (final) in parallel with the Triton X-100-treated samples. Both Triton X-100- and
OG-treated samples were homogenized with three passes of a glass pestle through a glass
Tenboeck tissue grinder. Sucrose was added to the homogenate (final concentration of 0.9
M) and overlayed with 1.0 ml of 0.8, 0.70, 0.65, 0.60, 0.55 and 0.50 M sucrose. The
homogenates were centrifuged at 40 000 r.p.m. for 20 h at 4°C. Two prominent bands were
recovered, designated DRM1 and DRM2; these were washed and resuspended in 0.2 ml of
Hepes buffer.
Western blot and GM1 analyses
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Samples (20 μl) were separated on 12% SDS-PAGE and then transferred to nitrocellulose.
The membrane was blocked with BLOTTO and then incubated with one of the following
primary antibodies for 18 h at 4°C (Shenker et al., 1999): anti-CdtA mAb (CdtA21), antiCdtB mAb (CdtB194), anti-CdtC mAb (CdtC63), anti-CD71 mAb (Santa Cruz
Biotechnology, Santa Cruz, CA) or anti-Lck mAb (Upstate Cell Signaling, Charlottesville,
VA). Membranes were washed, incubated with goat anti-mouse immunoglobulin (1:1000
dilution; Southern Biotechnology, Birmingham, AL) conjugated to horseradish peroxidase.
The Western blots were developed using chemiluminescence (ECL; Amersham Biosciences)
and analysed by digital densitometry (Kodak Image Systems). GM1 was detected by
spotting 1 μl directly on nitrocellulose membranes; samples were adjusted for phosphate
content. The membranes were blocked in BLOTTO and then incubated with CTB
conjugated to horseradish peroxidase (85 ng ml−1; Sigma Chemical) for 1 h. The membranes
were washed and analysed as described above.
Analysis of lipid composition
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Cholesterol was determined as described by Allain et al. (1974) and total phosphate as
described by Bartlett (1959). Lipids were extracted from the low-buoyant-density fractions
as previously described (Bligh and Dyer, 1959). Before the extraction of lipids from the
detergent solubilized fractions, samples were dialysed for 48 h against 10 mM Hepes, 0.5 M
NaCl, pH 7.4 to remove detergent. The extraction yield of total phospholipid was 90 ± 3.6%
indicating that the presence of residual detergent (Triton X-100 or OG) in the solubilized
fractions did not interfere with the extraction. Chloroform extracts were evaporated under
nitrogen and diluted into chloroform immediately before lipid analysis by gradient elution
using normal phase HPLC/ELSD (Avanti-Polar Lipids, Alabaster, AL). Standards 1 mg
ml−1 included: triolein, cholesterol, ceramide, oleic acid, phosphatidylglycerol (PG),
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS),
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phosphatidic acid (PA), soy-phosphatidylinositol (PI), and 0.5 mg ml−1 lysophosphatidylcholine (lyso-PC), lyso-phosphatidylethanolamine (lyso-PE), lysophosphatidylglycerol (lyso-PG) and lyso-phosphatidylserine (lyso-PS). Standards and
samples were injected on a normal phase HPLC column and analysed by an evaporative
light scattering detector (ELSD). A five-level calibration curve was used to calculate the
amount of lipid species in each sample.
Laser confocal microscopy
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Jurkat cells were incubated (2 × 106 ml−1) with CTB conjugated to AlexaFluor 647 (1 μg
ml−1; Molecular Probes) for 30 min at 4°C; after washing twice with medium, CTB was
cross-linked with goat anti-CTB sera (1:25 dilution; Calbiochem) for 30 min at 4°C
followed by an additional 45 min incubation at 37°C. Cells were washed and incubated with
Cdt holotoxin (2 μg ml−1) for 2 h at 37°C; after two washes the cells were blocked with
normal goat IgG (Southern Biotechnology), treated with anti-Cdt mAb for 30 min at 4°C,
washed, stained with goat anti-mouse Ig conjugated to biotin (1 μg; Southern
Biotechnology) for 30 min at 4°C, washed and exposed to streptavidin conjugated to FITC
(0.2 μg; Molecular Probes). The cells were then fixed in 2% paraformaldehyde, washed,
permeabilized with 0.1% sodium citrate and 0.1% Triton X-100 for 2 min, washed and
stained with DAPI (0.75 μM); stained cells were centrifuged and mounted onto microscope
slides using Fluoromount-G (Southern Biotechnology). Images of cells were taken on a BioRad Radiance 2100 confocal Microscope (Bio-Rad, Hercules, CA). DAPI, FITC and
AlexaFluor 647 fluorescence were excited by blue diode, argon (488 nm) and red diode
lasers respectively. Fluorescence emission was captured using the following filters: 376 ± 24
nm (DAPI); 515 ± 30 nm (FITC) and 660 nm and above (AlexaFluor 647). All images were
captured with the same laser settings. Analysis of fluorescent probe colocalization was
performed using image analysis software (Metamorph; Universal Imaging Corporation,
Downingtown, PA). Regions of interest were defined to include cells that did not overlap.
The region was segmented to select pixels above a constant threshold value (> 60% above
background) which represent true fluorescence. As both spatial location and intensity of
pixels contribute to colocalization, the values represent the integrated intensity; pixels in
both FITC and AlexaFluor 647 images had similar brightness values and spatial location.
Colocalization analysis was performed on all cells present in Figs 2–4.
Generation of anti-Cdt mAbs
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Recombinant Cdt holotoxin was expressed in E. coli using a plasmid containing all three cdt
genes (pUCAacdtABChis) as previously described; the His-tagged complex was purified by
nickel affinity chromatography (Shenker et al., 2004). Anti-Cdt mAbs were generated as
previously described (Lally et al., 1997). Briefly, BALB/c mice (Charles River Laboratories,
Wilmington, MA) 10–12 weeks old were immunized by IP injection with 10–20 μg Cdt
holotoxin on days 0, 10, 20 and 30 and allowed to rest for 30 days. Three days before fusion,
the animals received 10 μg of peptide intravenously. Splenocytes were fused to Sp2/0-Ag14
myeloma cells in the presence of 50% polyethylene glycol (Kodak 1450). The cells were
then dispersed in Kennett’s HY medium containing 20% FBS, glutamine, oxaloacetate,
pyruvate, hypoxanthine and azaserine and fed 7 days later in medium lacking azaserine.
Clones were visible 7–9 days after fusion and were first screened by Cdt ELISA. All mAbs
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were further screened by ELISA to identify the specific subunit with which they react as
well as by immunofluorescence to determine whether the antibody was able to recognize an
available epitope once the toxin had reacted with cells. Briefly, Jurkat cells were treated
with Cdt holotoxin (2 μg ml−1) for 2 h at 37°C; cells were then washed and treated with
varying amounts of anti-Cdt mAb for 30 min After washing the cells were first blocked with
normal goat IgG (Southern Biotechnology) and exposed to goat anti-mouse Ig conjugated to
biotin, washed, and treated with streptavidin-FITC (0.2 μg; Molecular Probes) for 30 min.
FITC fluorescence was assessed by flow cytometry as previously described (Shenker et al.,
2004).
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Detection of Cdt subunits associated with the Jurkat cell surface following treatment with
Cdt holotoxin. Jurkat cells were exposed to Cdt holotoxin (2 μg ml−1) for 2 h and then
treated with control murine IgG (dotted lines), anti-CdtA mAb [solid line in (A); mAb
Cdt162]; anti-CdtB mAb [solid line in (B); mAb Cdt171] or anti-CdtC mAb [solid line in
(C); mAb Cdt112]. Cells were then sequentially stained with goat anti-mouse Ig conjugated
to biotin and streptavidin conjugated to FITC and analysed by flow cytometry. FITC
fluorescence is plotted versus relative cell number. Numbers represent the mean channel
fluorescence (MCF); at least 10 000 cells were analysed per sample. Results are
representative of three experiments.
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Fig. 2.
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Colocalization of CdtA with GM1. Jurkat cells were treated with CTB conjugated to
AlexaFluor 647 and patched with anti-CTB sera. The cells were then treated with Cdt
holotoxin and stained with control IgG (A–C) or anti-CdtA (mAb162; D–I) as described in
Experimental procedures and assessed using laser confocal microscopy. Images of FITC
fluorescence (A, D and G) and AlexaFluor 647 fluorescence (B, E and H) are shown as well
as merged images (C, F and I) showing both FITC (green) and AlexaFluor 647 (red)
fluorescence along with DAPI-stained nuclei; colocalization is shown in yellow. Analysis of
the images indicate that >96% of CdtA fluorescence colocalizes with CTB fluorescence.
Results are representative of three experiments.
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Fig. 3.
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Colocalization of CdtB with GM1. Jurkat cells were treated with CTB conjugated to
AlexaFluor 647 and patched with anti-CTB sera. The cells were then treated with Cdt
holotoxin and stained with control IgG (A–C) or anti-CdtB (mAb171; D–I) as described in
Experimental procedures and assessed using laser confocal microscopy. Images of FITC
fluorescence (A, D and G) and AlexaFluor 647 fluorescence (B, E and H) are shown as well
as merged images (C, F and I) showing both FITC (green) and AlexaFluor 647 (red)
fluorescence along with DAPI-stained nuclei; colocalization is shown in yellow. Analysis of
the images indicates that 70% of CdtB fluorescence colocalizes with CTB fluorescence.
Results are representative of three experiments.
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Fig. 4.
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Colocalization of CdtC with GM1. Jurkat cells were treated with CTB conjugated to
AlexaFluor 647 and patched with anti-CTB sera. The cells were then treated with Cdt
holotoxin and stained with control IgG (A–C) or anti-CdtC (mAb112; D–I) as described in
Experimental procedures and assessed using laser confocal microscopy. Images of FITC
fluorescence (A, D and G) and AlexaFluor 647 fluorescence (B, E and H) are shown as well
as merged images (C, F and I) showing both FITC (green) and AlexaFluor 647 (red)
fluorescence along with DAPI-stained nuclei; colocalization is shown in yellow. Analysis of
the images indicates that >88% of CdtC fluorescence colocalizes with CTB fluorescence.
Results are representative of three experiments.
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Isolation of Jurkat cell DRMs. Jurkat cells were treated with Cdt holotoxin for 2 h and
DRMs were isolated as described in Experimental procedures. Two distinct low-buoyantdensity bands, designated DRM1 and DRM2, were obtained. The composition of these
bands was analysed to ascertain that they were indeed lipid rafts. DRM1, DRM2 and the
soluble fraction were assessed for cholesterol (bottom) and GM1 (dot blot). The protein
profile of the fractions was assessed by Western blot analysis for the presence of the raftassociated protein, Lck, which was enriched in these fractions. In contrast, the transferrin
receptor (CD71), a non-raft-associated protein, was found in the soluble fraction. Results are
representative of three experiments.
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Western blot analysis of Cdt peptides associated with DRMs. Jurkat cells were treated with
Cdt holotoxin, CdtB peptide or both CdtA and CdtC for 2 h; DRMs were isolated as
described in Experimental procedures. DRM1, DRM2 and the soluble fraction were
analysed for the presence of each Cdt peptide by Western blot analysis using mAb specific
for CdtA, CdtB and CdtC. The immunoblots were analysed by digitized scanning
densitometry; the numbers represent the relative distribution (%) of each subunit within
DRM1, DRM2 and the soluble (s) fractions respectively. Results are representative of three
experiments.
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Effect of MβCD on Cdt-induced cell cycle arrest. Jurkat cells were pre-treated with medium
(A), 2.5 mM (B), 5.0 mM (C) or 10 mM (D) MβCD for 30 min. The cells were washed,
exposed to Cdt holotoxin (40 pg ml−1), incubated for 18 h, stained with propidium iodide
and analysed for cell cycle distribution by flow cytometry. Cell cycle distribution is based
on DNA content (propidium iodide fluorescence) which is plotted versus relative cell
number. G0/G1 cells are found in the first peak (MCF of 75) and G2/M cells in the second
peak (MCF of 150); the percentage of cells in S phase was determined based on computer
modelling as noted in Experimental procedures. Numbers represent the percentage of cells
in the G0/G1, S and G2/M phases of the cell cycle. Results are representative of four
experiments; 15 000 cells were analysed for each sample. Parallel experiments verified that
MβCD did not adversely affect Jurkat cell viability as determined by propidium iodide
exclusion.

Author Manuscript
Cell Microbiol. Author manuscript; available in PMC 2016 January 29.

Boesze-Battaglia et al.

Page 21

Author Manuscript
Author Manuscript
Fig. 8.

Author Manuscript

Effect of MβCD and cholesterol-saturated MβCD on Cdt-induced cell cycle arrest. Jurkat
cells were pre-treated with medium (A and B), 10 mM MβCD (C) or cholesterol-saturated
MβCD (D) for 30 min, washed, exposed to Cdt holotoxin (40 pg ml−1; B–D), incubated for
18 h, stained with propidium iodide and analysed for cell cycle distribution by flow
cytometry as described. Numbers represent the percentage of cells in the G0/G1, S and
G2/M phases of the cell cycle. Results are representative of four experiments; 15 000 cells
were analysed for each sample.
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Cholesterol repletion in MβCD-treated cells restores susceptibility to Cdt. Jurkat cells were
first exposed to medium (A and B) or 5 mM MβCD (C–F) for 30 min. The cells were
washed and incubated for 30 min in the presence of medium (A–D) or cholesterol-saturated
MβCD (E and F; 0.5 mM). Cells were then incubated for 18 h in the presence of medium (A,
C and E) or Cdt holotoxin (40 pg ml−1; B, D and F), stained with propidium iodide and
analysed for cell cycle distribution by flow cytometry. Numbers represent the percentage of
cells in the G0/G1, S and G2/M phases of the cell cycle. Results are representative of three
experiments; 15 000 cells were analysed for each sample.
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Effect of cholesterol depletion on Cdt binding to Jurkat cells. Jurkat cells were pretreated
with medium (A, C, E and G) or 10 mM MβCD (B, D, F and H) for 30 min. The cells were
washed and treated with Cdt for 1 h. Jurkat cells were then washed and stained with control
IgG (A and B), anti-CdtA mAb (mAb162; C and D), anti-CdtB mAb (mAb171; E and F) or
anti-CdtC mAb (mAb112; G and H); cells were then exposed to goat anti-mouse IgG
conjugated to FITC as described in Experimental procedures. Cells were analysed by flow
cytometry for FITC fluorescence; numbers in each panel represent the MCF. Results are
representative of three experiments; at least 15 000 cells were analysed per sample.
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Lipid content of Jurkat DRMs (mole%).a
DRM1

DRM2

Lipid

Control

Cdt-treated

Control

Cdt-treated

SM

10.5 ± 2.3

  8.2 ± 1.2

11.8 ± 6.2

  9.7 ± 5.3

PC

54.3 ± 4.0

53.8 ± 5.7

39.7 ± 10.7

42.5 ± 7.3

PS

  7.7 ± 1.7

  7.5 ± 2.5

11.0 ± 5.3

  7.4 ± 0.5

PI

  6.2 ± 0.6

  5.2 ± 2.0

  6.1 ± 2.1

  4.0 ± 1.3

PE

20.8 ± 2.6

23.4 ± 1.3

22.8 ± 5.0

30.2 ± 13.2

PG

  0.2 ± 0.3

  0.2 ± 0.3

ND

ND

Lyso-PG

  2.7 ± 0.2

  1.6 ± 1.6

  0.7 ± 0.1

ND

PA

  5.0 ± 5.0

  0.7 ± 0.7

ND

ND
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Results are mean ± SEM of three experiments each performed in duplicate.

SM, sphingomyelin; PC, phosphatidylcholine; PS, phosphatidylserine; PI, phosphatidylinositol; PE, phosphatidylethanolamine; PG,
phosphatidylglycerol; PA, phosphatidic acid; ND, not detected.
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